New York Times(US:NYT) TMX Newsfile·2026-02-16 14:31Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Picard Medical, Inc. due to allegations of securities law violations, including misleading statements and undisclosed fraudulent activities [2][4]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses in Picard Medical between September 2, 2025, and October 31, 2025, to discuss their legal options [1]. - There is a deadline of April 13, 2026, for investors to seek the role of lead plaintiff in a federal securities class action against Picard Medical [2]. - The complaint alleges that Picard Medical and its executives made false statements and failed to disclose involvement in a fraudulent stock promotion scheme [4]. Group 2: Stock Performance and Impact - On October 24, 2025, Picard Medical's shares closed at $5.31, a significant drop from $13.20 on October 23, 2025, representing a decline of $7.89 per share or approximately 59.8% in a single trading session [5]. - This decline marks one of the most significant one-day drops since the company's recent IPO [5]. Group 3: Firm Background and Support - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its founding in 1995 and has offices in New York, Pennsylvania, California, and Georgia [3]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Picard Medical's conduct [7].